• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, April 1, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Antiplatelet drugs are often inappropriately prescribed in older patients

Bioengineer by Bioengineer
July 19, 2017
in Health
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A study has found that antiplatelet drugs, such as aspirin, are often inappropriately prescribed in acutely hospitalized older people.

Antiplatelet drugs are typically used to prevent conditions such as heart attacks and strokes, both for individuals at high risk (primary prevention) and for those who have already experienced one of these events (secondary prevention).

In the British Journal of Clinical Pharmacology analysis of nearly 2200 patients in Italian and Spanish internal medicine and geriatric clinical wards, 959 (44%) were prescribed an antiplatelet drug. Among patients prescribed for primary prevention, half of them were inappropriately prescribed (52%), being mainly overprescribed (155/209 patients, 74%). On the other hand, a high rate of inappropriate underprescription was also seen in the context of secondary prevention (222/726 patients, 31%).

###

Media Contact

Penny Smith
[email protected]

http://newsroom.wiley.com/

http://dx.doi.org/10.1111/bcp.13364

Share12Tweet8Share2ShareShareShare2

Related Posts

NADPH Enzymes Suppress Pancreatic Precancerous Lesions

April 1, 2026

Entorhinal Cortex Maps Remote Tasks Without CA1

April 1, 2026

Recombinant Protein Restores Platelet Function in Mice

April 1, 2026

ERAST Enables Scalable Homology Detection Breakthrough

April 1, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    96 shares
    Share 38 Tweet 24
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1006 shares
    Share 398 Tweet 249
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    43 shares
    Share 17 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

NADPH Enzymes Suppress Pancreatic Precancerous Lesions

Entorhinal Cortex Maps Remote Tasks Without CA1

Chikungunya Virus Lingers in Joint Macrophages, Causes Chronic Disease

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.